Early Phase Clinical Trials: Why taking the whole-of-health perspective is critical

In this webinar we hear from Professor Guy Ludbrook, Director of PARC Clinical Research, at the Royal Adelaide Hospital and Dr. Gabriel Kremmidiotis, Chief Scientific Officer at Avance Clinical, on how to navigate drug development, strategy and regulatory policy in planning early phase trials in Australia.

Professor Ludbrook has been involved in numerous investigator-initiated and industry sponsored clinical trials, as a Principal Investigator, Consultant, Monitor, and Data Safety Board member and has significant breadth and depth of knowledge and experience in clinical research.

Hear first-hand about the importance of planning with the end goal in mind while engaging and investing in subject matter expertise as early as possible in program drug development planning. The webinar will also cover:

• Delineating a full program development plan which includes Australia as an ideal program launch country.
• Work with the end goal in mind – what should be the key goals of your early clinical development planning and how can they best support future development
• Leveraging early CRO engagement in accessing KOL and clinical research unit expertise during the planning process and tapping into regulatory expertise .
• How to navigate ethics, regulatory approvals and achieve fast trial start.
• Strategies to selecting Australian investigators and research centers that are best suited to your investigational product
• Trial and investigational product types that can be conducted by PARC Clinical Research, at the Royal Adelaide Hospital – overview of the unit, its capabilities and experience

Gabriel Kremmidiotis, PhD, BSC Hon
Chief Scientific Officer

Guy Ludbrook Professor of Anaesthesia
Royal Adelaide Hospital

Shannon McGrath
Business Development Associate